Referred to the House Committee on Energy and Commerce.
This bill (Apeel Reveal Act of 2025) amends the Federal Food, Drug, and Cosmetic Act to require on-label disclosure when a fruit or vegetable has a "covered product coating" — defined as a coating applied directly to extend shelf life and explicitly including Apeel Sciences products such as Edipeel and Organipeel. The Secretary of Health and Human Services must issue guidance on the required disclosure within 180 days of enactment, and the labeling requirement will apply to fruits and vegetables labeled on or after one year after enactment.
Whether mandatory disclosure is primarily a pro-consumer transparency measure (liberal/centrist) or an unnecessary regulatory burden that could harm innovation and producers (conservative).
Relative to its intended legislative type, this bill is a focused substantive change that reasonably integrates into existing statutory enforcement by adding a misbranding disclosure requirement and delegating technical specifics to the Secretary of HHS.
This bill (Apeel Reveal Act of 2025) amends the Federal Food, Drug, and Cosmetic Act to require on-label disclosure when a fruit or vegetable has a "covered product coating" — defined as a coating applied directly to extend shelf life and explicitly including Apeel Sciences products such as Edipeel and Organipeel.
The Secretary of Health and Human Services must issue guidance on the required disclosure within 180 days of enactment, and the labeling requirement will apply to fruits and vegetables labeled on or after one year after enactment.
The provision is incorporated as a new subsection (z) of section 403 (prohibitions concerning misbranding).
On substance the bill is narrow, administrable, and low-cost, attributes that increase plausibility of enactment. However, the explicit inclusion of a named company's products is atypical, could provoke targeted opposition and legal/constitutional concerns, and makes it less likely to clear Senate procedural hurdles as a standalone bill. Absent strong bipartisan sponsorship or inclusion in a larger legislative vehicle, the path to law is uncertain.
Relative to its intended legislative type, this bill is a focused substantive change that reasonably integrates into existing statutory enforcement by adding a misbranding disclosure requirement and delegating technical specifics to the Secretary of HHS. It sets clear timelines for guidance and effectiveness but omits detailed labeling specifications, cost/resourcing acknowledgements, and mechanisms for monitoring compliance.
Whether mandatory disclosure is primarily a pro-consumer transparency measure (liberal/centrist) or an unnecessary regulatory burden that could harm innovation and producers (conservative).
These are examples from the analysis, not a ranked list of the most-affected groups.
Whether mandatory disclosure is primarily a pro-consumer transparency measure (liberal/centrist) or an unnecessary regulatory burden that could harm innovation and producers (conservative).
A mainstream progressive would likely view the bill positively for advancing consumer right-to-know and food transparency while also weighing potential tradeoffs.
They would welcome mandatory disclosure that helps consumers make informed choices and could help track corporate practices, but they would be concerned that a disclosure-only requirement might unintentionally stigmatize a technology that can reduce food waste.
They would want the HHS guidance to ensure disclosures are clear, science-based, and accompanied by context about safety and environmental impacts.
A pragmatic moderate would generally favor disclosure requirements as a modest, evidence-oriented policy that increases information for consumers while insisting on clear implementation rules.
They would welcome the statutory deadline for HHS guidance and the one-year phase-in, but would be focused on minimizing regulatory friction, compliance costs, and ambiguity (e.g., what counts as "labeling").
They would look for clear, standardized wording and an assessment of administrative burden, especially for small businesses and importers.
A mainstream conservative would be skeptical of this new federal labeling mandate as unnecessary regulatory expansion and potentially burdensome to producers and retailers.
They would question the need for separate disclosure given existing FDA oversight of food safety, be concerned about naming a private company in statute, and worry about costs, federal overreach, and negative effects on innovation and competitiveness.
They would prefer voluntary industry labeling, state-level solutions, or disclosure only when coatings present safety/allergen issues.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On substance the bill is narrow, administrable, and low-cost, attributes that increase plausibility of enactment. However, the explicit inclusion of a named company's products is atypical, could provoke targeted opposition and legal/constitutional concerns, and makes it less likely to clear Senate procedural hurdles as a standalone bill. Absent strong bipartisan sponsorship or inclusion in a larger legislative vehicle, the path to law is uncertain.
The bill has not accumulated any surfaced votes yet.
Whether mandatory disclosure is primarily a pro-consumer transparency measure (liberal/centrist) or an unnecessary regulatory burden that c…
On substance the bill is narrow, administrable, and low-cost, attributes that increase plausibility of enactment. However, the explicit inc…
Relative to its intended legislative type, this bill is a focused substantive change that reasonably integrates into existing statutory enforcement by adding a misbranding disclosure requirement and delegating technical…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.